{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-099553","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.006488+00:00","generated_at":"2026-05-17T03:35:53.331078+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Apimeds Pharmaceuticals amends bylaws to allow shareholder action by written consent","bullets":["Board adopted First Amendment to Bylaws on October 15, 2025, effective immediately.","Amendment permits shareholders to take action by written consent without a meeting.","Change provides shareholders an additional mechanism to act outside of annual or special meetings.","No other changes to the bylaws were made; full amendment filed as Exhibit 3.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-099553","json":"https://secwatch.observer/filing/0001213900-25-099553.json","markdown":"https://secwatch.observer/filing/0001213900-25-099553.md","text":"https://secwatch.observer/filing/0001213900-25-099553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea0261543-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:35:53.331078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ecf49b02f8210a4fd83e5a25c93e830b69dae7b5","claim":"Apimeds Pharmaceuticals US, Inc.: Bylaws amended to allow shareholder action by written consent (effective 2025-10-15).","evidence_excerpt":"On October 15, 2025, the board of directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) amended the bylaws to allow shareholder action by written consent.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-10-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}